BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 2881448)

  • 1. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I; Hirano A
    Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
    Chan-Palay V
    Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477
    [No Abstract]   [Full Text] [Related]  

  • 6. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
    Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleus basalis of Meynert in neurological dementing disease: a review.
    Chozick B
    Int J Neurosci; 1987 Nov; 37(1-2):31-48. PubMed ID: 2960633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.
    Pearson RC; Powell TP
    J Neural Transm Suppl; 1987; 24():139-46. PubMed ID: 3119773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.
    Rogers JD; Brogan D; Mirra SS
    Ann Neurol; 1985 Feb; 17(2):163-70. PubMed ID: 3883886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F; Pilleri G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S; Plas J; Massé G
    Encephale; 1986; 12(3):111-4. PubMed ID: 3769856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 16. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 17. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
    Förstl H; Levy R; Burns A; Luthert P; Cairns N
    Pharmacopsychiatry; 1994 Jan; 27(1):11-5. PubMed ID: 8159776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
    Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T; Bigl V; Tennstedt A; Arendt A
    Neurosci Lett; 1984 Jul; 48(1):81-5. PubMed ID: 6472737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of neuropathological and neurochemical correlates of Alzheimer's disease.
    Perry EK; Perry RH
    Dan Med Bull; 1985 Feb; 32 Suppl 1():27-34. PubMed ID: 2859148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.